Archives
-
LDH Cytotoxicity Assay Kit: Practical Guide
2026-10-01
The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive, colorimetric approach to cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is suitable for comparative cell damage and viability workflows, but it should not be used alone to identify the molecular mechanism of cell death or to distinguish apoptosis from other forms of membrane injury.
-
Cyclic Pifithrin-α hydrobromide Workflows
2026-09-30
Cyclic Pifithrin-α hydrobromide provides reversible control of p53-dependent transcription for apoptosis, DNA-damage, and growth-arrest experiments. This guide connects validated p53 workflows with carefully bounded hypotheses for neuroinflammatory assays involving the CGRP/SP-Piezo2 axis.
-
COMET: Transformer Design of Lipid Nanoparticles
2026-09-30
The reference study introduces COMET, a transformer-based model that represents complete lipid nanoparticle formulations rather than evaluating individual lipids in isolation. Trained on the LANCE dataset, COMET predicted formulation efficacy, transferred to non-canonical materials and smaller datasets, and helped identify candidates validated for RNA-associated protein expression in vitro and in vivo.
-
APEX2 Promotes TERT Expression in Human Stem Cells
2026-09-29
A 2024 bioRxiv preprint identifies APEX2 as a DNA repair enzyme required for efficient TERT expression in human embryonic stem cells and a melanoma cell line. Its RNA-seq and chromatin-immunoprecipitation results connect APEX2 activity with repetitive DNA elements, especially MIR sequences within TERT intron 2, suggesting a non-canonical link between DNA repair and telomerase regulation.
-
Cytarabine (AraC) Workflows for Apoptosis Research
2026-09-29
Cytarabine (AraC) provides a mechanistically grounded way to model DNA-replication stress, apoptosis, and resistance in leukemia systems. This guide pairs practical dose-response workflows with a cross-domain assay framework inspired by viral RIPK3 research, helping distinguish cytotoxicity from regulated cell-death pathway effects.
-
(-)-Blebbistatin for Cardiac Mechanobiology
2026-09-28
(-)-Blebbistatin gives researchers a reversible way to separate actomyosin-generated mechanics from temperature-sensitive cardiac electrical activity. This workflow positions a selective non-muscle myosin II inhibitor as a practical control for cytoskeletal dynamics research, contractility assays, and multimodal heart-rate experiments.
-
MTT Assays for Translational Thrombus Nanomedicine
2026-09-28
Thrombus-targeting performance changes with local blood flow, so translational studies need assays that separate delivery behavior from cellular response. This article examines how MTT can add a useful metabolic readout—while clarifying what it cannot establish about targeting or clinical efficacy.
-
Cardamomin Limits Oxidative Injury in Stroke Models
2026-09-27
A study of cardamomin from Amomum villosum Lour. links protection from hydrogen peroxide injury in BV-2 cells and cerebral ischemia in rats to MEK/ERK-dependent NRF2 activation and reduced AIFM1-associated cell death. The findings provide a mechanistic basis for further testing, while the models and reported assays do not yet establish clinical benefit or treatment efficacy after stroke.
-
Cyclic Pifithrin-α Hydrobromide in p53 Workflows
2026-09-26
Use this p53 inhibitor to test whether a stress phenotype depends on p53, while separating that question from broader DNA-damage or neuroinflammatory responses. A practical workflow pairs matched vehicle controls and p53-competent versus p53-deficient models with careful attention to stock handling and assay timing.
-
Topotecan HCl: Workflows for DNA-Damage Assays
2026-09-25
Use Topotecan HCl to probe topoisomerase 1-dependent DNA damage in cancer-cell workflows, from short cytotoxicity assays to longer sphere-forming studies. Practical dose ranges, handling guidance, and a carefully bounded connection to neuroinflammation research help researchers design interpretable experiments rather than assume one model predicts another.
-
Indomethacin: Practical Research Workflow Guide
2026-09-25
Indomethacin (SKU A8449) is a nonsteroidal anti-inflammatory drug for experiments examining cyclooxygenase activity and related inflammation research, with additional dossier-described PPAR and membrane effects. Use it with solvent-matched controls and endpoint-specific validation; it is not water-soluble, and the supplied product information does not establish a universal cell-treatment protocol or prove pathway specificity in a given model.
-
NiONPs, circ_0001944, and FXR/TLR4 in Fibrosis
2026-09-24
A 2025 study links hsa_circ_0001944 with FXR/TLR4 signaling and ferroptosis in nickel oxide nanoparticle–induced collagen formation. In rat and LX-2 cell models, FXR activation and circRNA overexpression were associated with reduced TLR4 expression and collagen deposition, highlighting a candidate pathway for further mechanistic study.
-
LDH Cytotoxicity Assay Kit: Workflow and QC
2026-09-24
The LDH Cytotoxicity Assay Kit measures LDH released into culture medium to support endpoint cell cytotoxicity measurement and cell damage quantification. It is useful for comparing membrane damage across treatment groups, but it does not identify a specific death pathway or replace mechanism-focused assays.
-
Viral RIPK3 Degradation Shapes Orthopoxvirus Inflammation
2026-09-23
Liu et al. identify a class of orthopoxvirus proteins that recruits host ubiquitin machinery to degrade RIPK3, suppressing necroptosis and altering viral replication and disease. The study connects this immune-evasion mechanism to host genotype and viral evolution, while highlighting why cell-death pathways must be distinguished when designing experiments.
-
Sulforaphane Workflows for Cancer and Inflammation
2026-09-23
Build reproducible Sulforaphane experiments that connect oxidative-stress biology with cell-cycle and inflammasome readouts. This guide translates cancer-cell and DSS-colitis evidence into practical dosing, assay-selection, and troubleshooting strategies.